Compare
HealthEquity vs Humana (HQY vs HUM)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year HealthEquity (HQY) returned +9.8% and Humana (HUM) +63.7%; so far this year the figures are +13.1% and +69.3%.
Humana is the larger company by market value, about 6.1 times the size of HealthEquity.
On trailing earnings, HQY trades at 37.4 times and HUM at 42.1 times.
Revenue grew +7.3% at HQY and +22.0% at HUM over the last year.
HQY pays no dividend. HUM yields 0.82%.
Data as of the latest close. Not investment advice.
Relative performance
| HQY | HUM | |
|---|---|---|
| Price | $103.63 | $433.74 |
| 1-day | +0.16% | +5.33% |
| YTD | +13.12% | +69.34% |
| 1 year | +9.79% | +63.71% |
| 3 years | +52.17% | -11.37% |
| Market cap | $8.6B | $52.1B |
| P/E | 37.4 | 42.1 |
| P/S | 6.29 | 0.34 |
| P/B | 4.31 | 2.77 |
| Revenue growth | +7.30% | +22.00% |
| EPS growth | +67.90% | -3.60% |
| Gross margin % | 71.2 | — |
| Net margin % | 17.4 | 0.8 |
| ROE % | 11.9 | 6.6 |
| Debt / equity | 0.47 | 0.66 |
| FCF yield % | 5.7 | 6.0 |
| Dividend yield % | — | 0.82 |
| Beta | 0.55 | 0.57 |
| RSI (14) | 59.3 | 61.1 |
| Technical rating |